← Back to Search

Other

Ceevra Reveal for Prostate Cancer

N/A
Waitlist Available
Led By James Porter, MD
Research Sponsored by Ceevra, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if using 3D virtual reality models from CT scans and MRIs helps surgeons perform prostate removal surgeries better. It aims to see if this technology can make operations quicker and improve patient care.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Postoperative PSA
Secondary study objectives
Androgen Deprivation or Radiation Therapy
Postoperative Erectile Function
Postoperative Urinary Function
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Intervention ArmExperimental Treatment1 Intervention
Subjects whose surgeon will be viewing Digital 3D models in addition to the source MR image and biopsy results in connection with the case.
Group II: Control ArmActive Control1 Intervention
Subjects whose surgeon will only be viewing MR images in connection with the case.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ceevra Reveal
2019
N/A
~220

Find a Location

Who is running the clinical trial?

Ceevra, Inc.Lead Sponsor
2 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Prostate Cancer
28 Patients Enrolled for Prostate Cancer
James Porter, MDPrincipal InvestigatorSwedish Medical Center
2 Previous Clinical Trials
489 Total Patients Enrolled
1 Trials studying Prostate Cancer
300 Patients Enrolled for Prostate Cancer
Raymond Pak, MDPrincipal InvestigatorMayo Clinic
~13 spots leftby Nov 2025